Etizolam Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.25 mg, 0.5 mg, 1 mg
Reference Brands: Depas®, Etilaam®, Etizest®(India & Japan)
Category:
Antipsychotropic Drugs
Etizolam, available in 0.25 mg to 1 mg tablets, is a fast-acting anxiolytic used for anxiety and insomnia. Though unapproved in the US/EU, it’s widely marketed in Asia under brands like Depas® and Etilaam®. Pharma B2B buyers can procure bulk Etizolam from GMP-approved, export-ready manufacturers.
Etizolam is available in Tablets
and strengths such as 0.25 mg, 0.5 mg, 1 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Etizolam is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Etizolam can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Etizolam is a thienodiazepine used for short-term treatment of anxiety, panic attacks, and insomnia. Though structurally similar to benzodiazepines, it offers rapid onset and fewer tolerance issues. Commonly available in 0.25 mg, 0.5 mg, and 1 mg tablets, Etizolam is widely marketed in Asian countries but is not FDA-approved in the US or broadly available in the EU. Brands include Depas®, Etilaam®, and Etizest®. Pharma B2B buyers can source Etizolam in bulk from GMP-certified facilities for regulated international markets. Ideal for psychiatric distributors and generic exporters seeking consistent supply of anxiolytic APIs or formulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing